Expensive formulation

Nov 1, 2009 1 related

While Astec Lifesciences has a stable revenue stream and bright prospects going ahead, it is asking for too steep a price for its shares. Agro-chemical company, Astec Lifesciences which manufactures intermediates, active... [read full story]

Add Comment

There are also 1 related articles

View all news articles about*:

*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies

Send to a friend | Bookmark with

NewstinMap

Click to Open NewstinMap —

Visual Navigation

My Newstin

Context

Finance, Banking & ...
Financial Markets
Economy
International Trade
Investing & Markets
Stock Capital Issues
Stock Markets
Manufacturing
Investing
Imports
Stock Price Changes
Corporate Performance

Astec
Syngenta

Intelligent Data Fusion

About Us

Visit our corporate homepage to learn more about our company and products.

Expensive formulation

View other selected articles:

Research and Markets: Automotive Glass - a Global Market Perspective - Slowdown in Automotive...

Research and Markets: Prostate Cancer Therapeutics - a Global Market Perspective

The Medicines Co. (MDCO) (Zacks.com)

Bayer MaterialScience to Set Up Joint Venture to Supply Polycarbonate Sheets to Indian Market

International Editions